InterventionsReview
Risk of protein intake deficiency during treatment with GLP-1 and GIP/GLP-1 receptor agonists: considerations for secondary sarcopenia
Advances in Therapy
- GLP-1 receptor agonists
- Liraglutide
- GLP-1 and incretin signalling
- Protein folding and chaperones
- Sarcopenia
- Humans
The paper
University of Liverpool · University of North Carolina at Chapel Hill
Advances in Therapy · 22 Aug 2026
